Literature DB >> 7097664

Diabetes mellitus and pregnancy: management and results.

H E Fadel, S D Hammond.   

Abstract

A protocol for the diagnosis and management of diabetes mellitus in pregnancy is outlined. It entails frequent prenatal visits, strict metabolic control, a program for antepartum fetal surveillance using estriols and contraction stress testing, liberal hospitalization, fetal lung maturity assessment, individualization of the time of induction of labor and careful intrapartum fetal monitoring. The results of such a protocol over a two-and-a-half-year period involving 84 gestational (GD) and 23 insulin-dependent (IDD) diabetic pregnant women is described. The incidence of preterm labor (less than 37 weeks) was 7.1% in GD and 39% in IDD. The cesarean section rate was 15.4% in GD and 56.5% in IDD. The incidence of macrosomia was 20% in GD and 13% in IDD. There was one antepartum stillbirth in GD due to a true knot of the cord, and there were no neonatal deaths in either group, for a perinatal mortality rate of less than 1%. Neonatal morbidity was also decreased. Respiratory distress syndrome occurred in only one neonate of an IDD. The success of such a protocol in decreasing perinatal morbidity and mortality justifies the effort and cost expended.

Entities:  

Mesh:

Year:  1982        PMID: 7097664

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

Review 1.  Screening for diabetes in pregnancy.

Authors:  S Virjee; S Robinson; D G Johnston
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

Review 2.  Reducing stillbirths: screening and monitoring during pregnancy and labour.

Authors:  Rachel A Haws; Mohammad Yawar Yakoob; Tanya Soomro; Esme V Menezes; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

Review 3.  Effect of screening and management of diabetes during pregnancy on stillbirths.

Authors:  Madiha Syed; Hasan Javed; Mohammad Yawar Yakoob; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.